BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20551310)

  • 1. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.
    Bawa-Khalfe T; Cheng J; Lin SH; Ittmann MM; Yeh ET
    J Biol Chem; 2010 Aug; 285(33):25859-66. PubMed ID: 20551310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-specific protease 1 promotes prostate cancer progression and metastasis.
    Wang Q; Xia N; Li T; Xu Y; Zou Y; Zuo Y; Fan Q; Bawa-Khalfe T; Yeh ET; Cheng J
    Oncogene; 2013 May; 32(19):2493-8. PubMed ID: 22733136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress.
    Wen P; Li H; Liu L; Liu X; Xu Z; Dong J
    Technol Cancer Res Treat; 2024; 23():15330338241257490. PubMed ID: 38803001
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
    Li T; Huang S; Dong M; Gui Y; Wu D
    Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells.
    Wang C; Tao W; Ni S; Chen Q
    Int J Biol Sci; 2019; 15(2):395-403. PubMed ID: 30745829
    [No Abstract]   [Full Text] [Related]  

  • 6. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.
    Cheng J; Kang X; Zhang S; Yeh ET
    Cell; 2007 Nov; 131(3):584-95. PubMed ID: 17981124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of desumoylation in the development of prostate cancer.
    Cheng J; Bawa T; Lee P; Gong L; Yeh ET
    Neoplasia; 2006 Aug; 8(8):667-76. PubMed ID: 16925949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis.
    Xu Y; Zuo Y; Zhang H; Kang X; Yue F; Yi Z; Liu M; Yeh ET; Chen G; Cheng J
    J Biol Chem; 2010 Nov; 285(47):36682-8. PubMed ID: 20841360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SENP‑1 enhances hypoxia‑induced proliferation of rat pulmonary artery smooth muscle cells by regulating hypoxia‑inducible factor‑1α.
    Zhou F; Dai A; Jiang Y; Tan X; Zhang X
    Mol Med Rep; 2016 Apr; 13(4):3482-90. PubMed ID: 26935971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
    Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SENP1 regulates PTEN stability to dictate prostate cancer development.
    Bawa-Khalfe T; Yang FM; Ritho J; Lin HK; Cheng J; Yeh ET
    Oncotarget; 2017 Mar; 8(11):17651-17664. PubMed ID: 27852060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway.
    Gu J; Fan Y; Liu X; Zhou L; Cheng J; Cai R; Xue S
    Cardiovasc Res; 2014 Oct; 104(1):83-92. PubMed ID: 25082844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
    Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
    Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells.
    Bawa-Khalfe T; Cheng J; Wang Z; Yeh ET
    J Biol Chem; 2007 Dec; 282(52):37341-9. PubMed ID: 17932034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
    Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
    Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
    Ao Q; Su W; Guo S; Cai L; Huang L
    Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia maintains the fenestration of liver sinusoidal endothelial cells and promotes their proliferation through the SENP1/HIF-1α/VEGF signaling axis.
    Qing Z; Huang H; Yang S; Lin J; Zeng Z; Duan J; Yuan B; Ming T
    Biochem Biophys Res Commun; 2021 Feb; 540():42-50. PubMed ID: 33445109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of SENP1 expression increases apoptosis of Burkitt lymphoma cells.
    Huang BB; Gao QM; Liang W; Xiu B; Zhang WJ; Liang AB
    Asian Pac J Cancer Prev; 2012; 13(5):2045-9. PubMed ID: 22901169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia.
    Kang X; Li J; Zou Y; Yi J; Zhang H; Cao M; Yeh ET; Cheng J
    Oncogene; 2010 Oct; 29(41):5568-78. PubMed ID: 20661221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
    Witty J; Aguilar-Martinez E; Sharrocks AD
    Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.